Our previous study demonstrated that the EGFR was expressed in all patients with NPC, and it has been suggested that the over-expression of EGFR in NPC is correlated with an aggressive malignant progression and poor survival rates (11,12). The gene discussed is EGFR; the disease is nasopharyngeal carcinoma.